Dimitrios C. Ziogas
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Cancer Immunotherapy and Biomarkers, Amyloidosis: Diagnosis, Treatment, Outcomes, CAR-T cell therapy research, Protein Degradation and Inhibitors
Most-Cited Works
- → Immunotherapy for pancreatic cancer: A 2020 update(2020)498 cited
- → Catechol-O-Methyltransferase val158met Polymorphism Predicts Placebo Effect in Irritable Bowel Syndrome(2012)202 cited
- → Reactivation of tuberculosis in cancer patients following administration of immune checkpoint inhibitors: current evidence and clinical practice recommendations(2019)122 cited
- → Cardiac and renal complications of carfilzomib in patients with multiple myeloma(2017)104 cited
- → Mechanisms of resistance to immune checkpoint inhibitors in melanoma: What we have to overcome?(2022)97 cited
- → Predicting the Outcome of Sjogren’s Syndrome-Associated Non-Hodgkin’s Lymphoma Patients(2015)93 cited
- → Bortezomib‐based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis(2016)91 cited
- → Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma(2016)86 cited
- → Latest evidence on immune checkpoint inhibitors in metastatic colorectal cancer: A 2022 update(2022)75 cited
- → Renal outcomes in patients with AL amyloidosis: Prognostic factors, renal response and the impact of therapy(2017)70 cited